# 



## 

## 

||obeq|
|---|---|
|LdOdaySAalsnyl|L|
|SAILIMGISNOdSAYSAALSNYLJOLNSAINSLVIS|v|
|LYOd4yS.YOLIGNVLINSGQNSdSqNI|S|
|SAILLIALLOVTVIONVNId40LNSWSALVLS|Z|
|L35dHSSAONVIVa|8|
|SLNNOOOVSHLOLSALON|6|





## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 




## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

||Unrestricted|Endowment|Total|Unrestricted|Endowment|Total|
|---|---|---|---|---|---|---|
||Fund|Fund|Fund|Fund|Fund|Fund|
||2024|2024|2024|2023|2023|2023|
||£|£|£|£|£|£|
|Incomefrom:|||||||
|Investments|101,424|-|101,424|97,035|-|97,035|
|Expenditureon:|||||||
|Charitableactivities|98,718|-|98,718|90,245|-|90,245|
|(Note3)|||||||
|Netgains/(losses)|||||||
|oninvestments(Note<br>4)|-|192,390|192,390|-|(236,871)|(236,871)|
|NetIncome/|||||||
|(Expenditure)|2,706|192,390|195,096|6,790|(236,871)|(230,081)|
|TotalFundsbrought|||||||
|forwardat1April|||||||
|2023|141,533|2,429,173|2,570,706|134,743|2,666,044|2,800,787|
|TotalFundscarried|||||||
|forwardat31March|||||||
|2024|144,239|2,621,563|2,765,802|141,533|2,429,173|2,570,706|
|Allamountsrelateto|continuingoperations||||||





## 

||||2024||023|
|---|---|---|---|---|---|
||Note|£|£|£|£|
|FIXEDASSETS||||||
|Investments|4||2,621,563||2,429,173|
|CURRENTASSETS||||||
|Accruedincome|5|6,655||5,870||
|BankBalances||275,589||306,150||
||||282,244||312,020|
|CREDITORS:AMOUNTSFALLING|<br>6|||||
|DUEWITHINONEYEAR|||(138,005)||(170,487)|
|NETASSETS|||2,765,802||2,570,706|
|Representing:||||||
|FUNDS||||||
|EndowmentFunds|2,9,10||2,621,563||2,429,173|
|UnrestrictedFunds|9,10||144,239||141,533|
||||2,765,802||2,570,706|






## 

## 



## 

|ANALYSISOFEXPENDITURE||||||
|---|---|---|---|---|---|
||Direct|Support||<br>Total|Total|
||costs|costs||<br>2024|2023|
||£|£||£|£|
|GrantstoNorthLondonCollegiateSchool||||||
|MusicScholarshipawards|46,000||-|<br>46,000|45,000|
|AdvancementofEducationinScience||||||
|-ScienceEquipment|-||~|<br>-|10,510|
|-ScienceLaboraiories|33,000||-|<br>33,000|33,000|
|Annual SciencePrize|225||~|<br>225|150|
|Othercharitable andeducationalpurposes||||||
|-SupplementarygrantstoBursary Holders|3,000||~|<br>3,000|4,000|
|-Choralandinstrumentalmasterclasses|10,500||-|<br>10,500|2,250|
|-Extendedessaysandsciencedisplays|8,500||-|<br>8,500|-|
|UnusedamountsreturnedtoTrust|(6,287)||“|<br>(6,287)|(8,265)|
|Governance||||||
|Auditfee|-|3,780||3,780|3,600|
|Total|94,938|3,780||98,718|90,245|
|INVESTMENTS||||||
|InvestmentsoftheTrustcomprise:||||Market|value|
|||||2024|2023|
|||||£|£|
|UKlistedequities-Glaxo||||300,714|251,504|
|-Haleon||||73,282|-|
|M&GEquitiesFundforCharities||||815,405|830,575|
|BlackRockCharitiesEquitiesFund||||101,239|98365|
|COIFCharitiesInvestmentFund||||662,200|606,492|
|BlackRockGrowthandIncomeFund||||294,367|287,886|
|COIFCharitiesFixedInterestFund||||254,260|242,702|
|NewtonGrowthandIncomeFund||||120,096|111,649|
|||||2,621,563|2,429,173|
|Movementsduringtheyearwere:||||||
|||||Market|Market|
|||||Value2024|Value2023|
|||||£|£|
|Broughtforwardat7April2023||||2,429,173|2,666,044|
|Unrealisedgains/(losses)||||192,390|(236,871)|
|Carriedforwardat31March2024||||2,621,563|2,429,173|
|Investmentmanagerfeesarerecoveredwithinpooledinvestment||funds||||





## 

||ACCRUEDINCOME|||2024|2023|
|---|---|---|---|---|---|
|||||£|£|
||GlaxoSmithKlineincome|||2,800|2,420|
||NewtonGrowthandIncomeFund|||500|400|
||BlackRock-InvestmentFunds|||3,355|3,050|
|||||6,655|5,870|
|6|CREDITORS|||2024|2023|
|||||£|£|
||NorthLondonCollegiateSchool|||134,225|166,887|
||Othercreditors|||3,780|3,600|
|||||138,005|170,487|
||TRUSTEES|||||
||NoneoftheTrusteesreceivedanyremuneration.|||||
||NETMOVEMENTINFUNDS|||||
||Netmovementinfundsfortheyearisstatedaftercharging||thefollowing:|||
|||||2024|2023|
|||||£|£|
||Amountspaidtoauditors|||||
||Auditservices—CroweU.K.LLP|||3,780|3,600|
|||||3,780|3,600|
||ANALYSISOFNETASSETSBETWEENFUNDS|||||
||Fundbalancesat31March2024are|representedby:||||
|||||Total|Total|
|||Unrestricted|Endowment|Funds|Funds|
|||Funds|Funds|2024|2023|
|||£|£|£|£|
||FixedAssetsandInvestments|-|2,621,563|2,621,563|2,429,173|
||CurrentAssets|282,244|-|282,244|312,020|
||Creditors|||||
||Amountsfallingduewithinoneyear|(138,005)|-|(138,005)|(170,487)|
||Carriedforwardat31March2024|144,239|2,621,563|2,765,802|2,570,706|





## 

|||At1April|||Unrealised|At31March|
|---|---|---|---|---|---|---|
|||2023|Income|Expenditure|gain|2024|
|||£|£|£|£|£|
||EndowmentFunds|2,429,173|-|-|192,390|2,621,563|
||UnrestrictedFunds|141,533|101,424|(98,718)|-|144,239|
||Total|2,970,706|101,424|(98,718)|192,390|2,765,802|
|11|COMPARATIVENOTES-ANALYSISOFNETASSETS|||BETWEENFUNDS|||
||Fundbalancesat31March|2023arerepresentedby:|||||
||||||Total|Total|
||||Unrestricted|Endowment|Funds|Funds|
||||Funds|Funds|2023|2022|
||||£|£|£|£|
||FixedAssetsandinvestments||-|2,429,173|2,429,173|2,666044|
||CurrentAssets||312,020|-|312,020|217,444|
||Creditors||||||
||Amountsfallingduewithin|oneyear|(170,487)|<br>-|<br>(170,487)|(82,701)|
||Carriedforwardat31March|2023|141,533|2,429,173|2,570,706|2,800,787|
||COMPARATIVENOTES-STATEMENT||OFFUNDS||||
|||At1April|||(Realisedloss)|At31March|
|||2022|Income|Expenditure|unrealisedgain|2023|
|||£|£|£|£|£|
||EndowmentFunds|2,666,044|-|-|(236,871)|2,429,173|
||UnrestrictedFunds|134,743|97,035|(90,245)||141,533|
||Total|2,800,787|97,035|(90,245)|(236,871)|2,570,706|





## 

## 

##